Shan Yong Yi

Summary

Country: China

Publications

  1. doi Cancer stem cells niche: a target for novel cancer therapeutics
    Shan Yong Yi
    Department of Oncology of the Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zheng Zhou 450007, Henan Province, China
    Cancer Treat Rev 39:290-6. 2013
  2. doi New insights into metronomic chemotherapy-induced immunoregulation
    Yi Bin Hao
    Cancer Center of the First Affiliated Hospital, College of Medicine of Xi an Jiaotong University, Xi an 710061, Shanxi, China Department of Oncology of the Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zheng Zhou 450007, Henan, China
    Cancer Lett 354:220-6. 2014

Collaborators

  • Yi Bin Hao
  • Jing Ruan
  • Ling Zhao
  • Ke Jun Nan

Detail Information

Publications2

  1. doi Cancer stem cells niche: a target for novel cancer therapeutics
    Shan Yong Yi
    Department of Oncology of the Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zheng Zhou 450007, Henan Province, China
    Cancer Treat Rev 39:290-6. 2013
    ....
  2. doi New insights into metronomic chemotherapy-induced immunoregulation
    Yi Bin Hao
    Cancer Center of the First Affiliated Hospital, College of Medicine of Xi an Jiaotong University, Xi an 710061, Shanxi, China Department of Oncology of the Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zheng Zhou 450007, Henan, China
    Cancer Lett 354:220-6. 2014
    ..Understanding of the molecular mechanisms of metronomic chemotherapy-induced immunoregulation may yield invaluable information for the optimal design of immunochemotherapies. ..